Concerns About Ozempic and Wegovy Hair Loss Rising Among Consumers

Some users say the Ozempic and Wegovy hair loss does not appear to be linked to weight loss caused by the diabetes drugs

While the diabetes drugs Ozempic and Wegovy are increasingly being prescribed for weight loss, a growing number of reports seem to suggest that users are not just losing pounds, but that side effects of the medications may be causing hair loss as well.

According to a NBC News report published on April 22, users of the two drugs are posting concerns on social media sites indicating their hair appears to be falling out after taking Ozempic or Wegovy.

Ozempic and Wegovy are the brand names for the diabetes drug semaglutide, which were originally approved for the treatment of people with Type 2 diabetes. However, in recent months the medications have been increasingly prescribed for weight loss. While Wegovy has FDA approval for weight loss uses, Ozempic does not, and is prescribed “off-label” as a diet medication by a growing number of doctors.

The new report points out several social media posts by users on platforms such as Reddit and others, who are alarmed to find their hair falling out after taking the medications.

“Anyone lost most of their hair with Ozempic? Talked to doc several times about it but they keep telling me the drug does not cause hair loss,” one Reddit user stated. “I requested an oral minoxidil prescription but they wouldn’t give it to me. Should I stop Ozempic?”

While clinical trials linked Wegovy to triple the risk of hair loss when compared to those who took a placebo, no such side effects are listed in reference to Ozempic, which is typically given at a much lower dose.

Manufacturers and some health experts say the hair loss, known as alopecia, may be related to the weight loss the drugs are causing. Patients undergoing weight loss surgery are often warned of the risk of hair loss due to the body’s attempt to conserve resources, but some consumers say there appears to be something more serious happening.

Find Out If You Have a Lawsuit

Were you prescribed Ozempic, Wegovy or Mounjaro?

Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects

Learn More About this Lawsuit See If You Qualify for Compensation

Another post, concerning Wegovy hair loss noted the condition does not seem to be related to the actual weight loss.

“This is not normal hair shedding. This is gobs and gobs of hair every time I take a shower,” the poster wrote. “It’s not from weight loss. I’ve lost 40lbs before low calorie without a shot and experienced NOTHING like this.”

Health experts interviewed by NBC recommended maintaining a healthy diet, including plenty of protein, iron, B vitamins and zinc to help combat potential hair loss related to rapid weight loss.


Find Out If You Qualify for Ozempic or Wegovy Compensation

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

New Port Catheter Lawsuits Against AngioDynamics Can Now Be Directly Filed in Federal MDL
New Port Catheter Lawsuits Against AngioDynamics Can Now Be Directly Filed in Federal MDL (Posted today)

A federal judge has approved the direct filing of AngioDynamics port catheter lawsuits in the U.S. District Court for the District of Southern California, where the litigation has been centralized for coordinated discovery and pretrial proceedings.

MDL Panel To Consider Depo-Provera Brain Tumor Lawsuit Consolidation at Hearing Today
MDL Panel To Consider Depo-Provera Brain Tumor Lawsuit Consolidation at Hearing Today (Posted yesterday)

The U.S. JPML will hear oral arguments today over the potential creation of a Depo-Provera brain tumor lawsuit multidistrict litigation, which would place all of the federal cases under one judge for coordinated pretrial proceedings.